key: cord-0728402-fnpm5tzl
authors: Hoffmann, H.-Heinrich; Schneider, William M.; Rozen-Gagnon, Kathryn; Miles, Linde A.; Schuster, Felix; Razooky, Brandon; Jacobson, Eliana; Wu, Xianfang; Yi, Soon; Rudin, Charles M.; MacDonald, Margaret R.; McMullan, Laura K.; Poirier, John T.; Rice, Charles M.
title: TMEM41B Is a Pan-flavivirus Host Factor
date: 2021-01-07
journal: Cell
DOI: 10.1016/j.cell.2020.12.005
sha: 2b8894353f07a092032aa1ddaf7590271ce3fe40
doc_id: 728402
cord_uid: fnpm5tzl

Flaviviruses pose a constant threat to human health. These RNA viruses are transmitted by the bite of infected mosquitoes and ticks and regularly cause outbreaks. To identify host factors required for flavivirus infection, we performed full-genome loss of function CRISPR-Cas9 screens. Based on these results, we focused our efforts on characterizing the roles that TMEM41B and VMP1 play in the virus replication cycle. Our mechanistic studies on TMEM41B revealed that all members of the Flaviviridae family that we tested require TMEM41B. We tested 12 additional virus families and found that SARS-CoV-2 of the Coronaviridae also required TMEM41B for infection. Remarkably, single nucleotide polymorphisms present at nearly 20% in East Asian populations reduce flavivirus infection. Based on our mechanistic studies, we propose that TMEM41B is recruited to flavivirus RNA replication complexes to facilitate membrane curvature, which creates a protected environment for viral genome replication.

Correspondence john.poirier@nyulangone.org (J.T.P.), ricec@rockefeller.edu (C.M.R.) In Brief Hoffmann et al. determine that the transmembrane protein, TMEM41B, is required for infection by members of the Flaviviridae family of viruses. Loss of TMEM41B reduces viral RNA replication and increases innate immune activation in response to flavivirus infection. Thus, TMEM41B is a potential host target for antiviral therapeutics.

Virus outbreaks are a regular yet unpredictable feature of an interconnected world. Flaviviruses are known to cause outbreaks worldwide and are transmitted primarily by the bite of infected mosquitoes and ticks.

Flaviviruses, members of the Flaviviridae family, are positivesense single-stranded RNA viruses that have caused several notable outbreaks in recent history. For example, West Nile virus (WNV) emerged in New York City in 1999, spread across the continent, and is now endemic in the United States (Kramer et al., 2019; Roehrig et al., 2002) . Also noteworthy are the recurring yellow fever virus (YFV) outbreaks that occur in sub-Saharan Africa and South America despite the availability of a highly effective vaccine (Ahmed and Memish, 2017; WHO, 2017) . Most recently, the 2016 Zika virus (ZIKV) epidemic swept through South and Central America wreaking havoc on scores of unborn children by causing microcephaly in utero (Hills et al., 2017; Lee and Ng, 2018) . In addition to these outbreaks, Aedes albopictus, a vector for ZIKV and dengue virus (DENV) has been found consistently in recent years in central Europe (Mü ller et al., 2020) , and the prevalence of tick-borne diseases is at a record high. These alarming trends correlate with warming temperatures due to climate change, which expand the range of mosquitoes and ticks (Brady and Hay, 2020; Brugueras et al., 2020; Dobler, 2010; McPherson et al., 2017; Medlock et al., 2013) . These recent flavivirus outbreaks add to the constant burden of endemic DENV transmission and underscore the devastating impacts that flaviviruses have on human health. For many viruses with the potential to cause outbreaks, there are no specific treatments. In instances where antiviral therapies do exist, they are often virus specific. One strategy to prepare for and respond to viral outbreaks is to develop drugs that target host factors that viruses require to complete their replication cycles. CRISPR-Cas9 gene disruption has been used to identify host factors required for virus infection and nominate candidate drug targets. We, like others, set out to identify factors required for ZIKV as well as other flaviviruses with a genome-wide loss of function CRISPR-Cas9 screening approach. Here, we present our results and detailed studies focused on two genes, transmembrane protein 41B (TMEM41B) and vacuole membrane protein 1 (VMP1), that were enriched in our screens. Article RESULTS Genome-wide CRISPR-Cas9 Screens for Zika and Yellow Fever Viruses Identify TMEM41B and VMP1 as Required Host Factors To identify host factors required for ZIKV and YFV, we performed pooled genome-wide CRISPR knockout (KO) screens in B3GALT6-deficient human haploid (HAP1) cells with ZIKV (PRVABC59 strain) and YFV (Asibi strain). The readout for these screens was cell survival. We used B3GALT6 KO cells aiming to decrease cellular heparan sulfate (HS) protein glycosylation, which has been shown to nonspecifically facilitate virus binding and subsequent entry (Cagno et al., 2019) . We hypothesized that this alteration in surface protein glycosylation would decrease the enrichment and overabundance of hits related to HS protein glycosylation and nonspecific virus binding. Nevertheless, consistent with a wide range of virus-selected genome-wide loss-of-function screens (Hoffmann et al., 2017; Jae et al., 2014; Realegeno et al., 2017; Riblett et al., 2015) , we identified host factors involved in heparan sulfate biosynthesis. Like other flavivirus host factor screens, we identified genes that are involved in oligosaccharide transfer and genes involved in protein translocation and folding into the endoplasmic reticulum (ER) ( Figure 1A ) (Marceau et al., 2016; Savidis et al., 2016; Zhang et al., 2016) . Outside of these categories, TMEM41B was enriched in both ZIKV and YFV screens. While several of the abovementioned pathways have been studied in the context of flavivirus infection (Marceau et al., 2016; Ngo et al., 2019; Zhang et al., 2016) , little is known about the cellular function of TMEM41B or its role in flavivirus infection. TMEM41B was previously found to be required for synaptic transmission in motor circuit neurons (Imlach et al., 2012; Lotti et al., 2012) , and three independent genome-wide CRISPR-Cas9 loss of function screens identified it as a gene that plays an important role in autophagy (Moretti et al., 2018; Morita et al., 2019; Shoemaker et al., 2019) . These groups went on to show that TMEM41B is functionally similar to VMP1, which is known to have a role in lipid mobilization and autophagy (Morishita et al., 2019; Ropolo et al., 2007; Zhao et al., 2017) .

There are numerous, sometimes conflicting reports, which indicate that autophagy-related genes can promote or restrict Flaviviridae infection. This literature has been recently reviewed by Po-Yuan Ke (Ke, 2018) . Our identification of TMEM41B prompted us to interrogate our screen data further for genes involved in autophagy. Of a list of genes with an established role in autophagy, only TMEM41B and VMP1, which act at the early stage of autophagy, scored positively (Figure 1B) . This list, however, is not comprehensive, and therefore we next compared our ZIKV screen results to those from a genomewide CRISPR-Cas9 screen that was designed to identify novel genes required for autophagy (Moretti et al., 2018) . As shown in Figure 1C , these two screens showed no overlap with the exception of two genes: TMEM41B and VMP1.

The VTT Domain Proteins TMEM41B and VMP1 Are Required for Flavivirus Infection TMEM41B and VMP1 are multipass transmembrane proteins that share a stretch of amino acids recently named the VTT domain based on homology among VMP1, TMEM41A /B, and TMEM64 (Morita et al., 2019) . Given this homology and the fact that both TMEM41B and VMP1 scored as hits in our flavivirus screens, we tested all four members of the VTT domain family for their requirement in flavivirus infection. Further, in addition to ZIKV and YFV (strain: Asibi) used in our screens, we included three additional flaviviruses: YFV 17D (vaccine strain), DENV-2, and WNV.

To test which of the four VTT domain-containing proteins are required for flavivirus infection, we used CRISPR-Cas9 gene disruption to generate clonal HAP1 cell lines individually lacking VMP1, TMEM41A, TMEM41B, and TMEM64 ( Figure S1A ). We then infected three to five independent KO clones for each of these candidate host factors with each of the five flaviviruses listed above or with human parainfluenza virus 3 (hPIV-3) as a non-flavivirus control. Consistent with our screening results, we found that of these four VTT domain-containing proteins, only TMEM41B and VMP1 are required for flavivirus infection ( Figures 1D, 1H , S1B, S1D, and S1F). While TMEM41B was not required for hPIV-3 infection, decreased growth of hPIV-3 was observed in the VMP1 KO clones (Figure S1H ). VMP1 KO clones appear less viable and grow slower compared to wild-type (WT) cells, which likely accounts for the slight decrease in replication seen for hPIV-3.

We next expressed each of the four VTT domain-containing proteins individually in TMEM41B KO (A) Bubble plot of genes significantly enriched in a genome-wide CRISPR KO screen in HAP1 cells challenged with ZIKV (top) and YFV (bottom). Colors indicate association with cellular pathways or protein complexes and domains. Red lines denote Z = ± 2. (B) Heatmap of Z scores for genes in the autophagy pathway ordered sequentially by functional role: L, lipid mobilization; 1, initiation; 2, nucleation; 3, elongation; 4, sequestration; 5, tethering/fusion. Rows represent replicate screens. Morita et al., 2019; Ropolo et al., 2007; Shoemaker et al., 2019) . To test this, we generated clones lacking BECN1, ATG5, and ATG7, which are known to play a critical role in autophagy (Kang et al., 2011; Mizushima et al., 1998; Tanida et al., 1999) . We confirmed KO in these clones by genome sequencing as well as by western blot (for ATG5 and ATG7) ( Figure S2A ). ATG5 and ATG7 KO clones lack lipidated LC3 II at baseline levels, indicative of defective autophagy (Tanida et al., 2008; Tanida and Waguri, 2010 ). We then further tested ATG7 KO clones for their ability to respond to classical autophagy stimuli (e.g., starvation and treatment with Torin 1 in the presence of chloroquine). As expected, ATG7-deficient cells are unable to undergo autophagy. This is shown by western blot in Figure S2B , where autophagy induction leads to LC3 I lipidation and conversion to LC3 II in WT cells but not in ATG7 KO HAP1 clones (Tanida et al., 2008; Tanida and Waguri, 2010) . We then tested these autophagy-deficient cells for their ability to support flavivirus infection and found that cells lacking BECN1, ATG5, or ATG7 retained their ability to support flavivirus infection ( Figures 1G, 1K , S1C, S1E, S1G, and S1I). These data suggest that in this cell type, canonical autophagy is not required for flavivirus infection. This does not, however, exclude a requirement for non-canonical autophagy mechanisms nor does it suggest TMEM41B and VMP1 are the only autophagy factors required for flavivirus infection. In fact, two other non-classical autophagy genes were enriched in our YFV screen (TBC1D5 and TBC1D20) and in our ZIKV screen (TBC1D20) underscoring the complex interplay between flavivirus replication and the autophagy pathway (Popovic et al., 2012; Popovic and Dikic, 2014; Sidjanin et al., 2016; Sklan et al., 2007) (Figures 1A and 1B ).

To gain additional insight into the requirement of TMEM41B for flavivirus infection, we extended our studies to include tick-borne flaviviruses, viruses from additional genera within the Flaviviridae family, and a diverse panel of unrelated viruses. The tick-borne flaviviruses we tested include Powassan virus (POWV), a biosafety level 3 (BSL3) pathogen currently expanding in North America in Ixodes ticks (Dennis et al., 1998; Ebel, 2010; Eisen et al., 2016) , and five BSL4 pathogens: two strains of tickborne encephalitis virus (TBEV) representing the European and Far Eastern clade and three hemorrhagic fever viruses, Omsk hemorrhagic fever virus (OHFV), Kyasanur forest disease virus (KFDV), and Alkhurma hemorrhagic fever virus (AHFV). In addition, we generated TMEM41B KO clones in hepatocellular carcinoma cells (Huh-7.5) and bovine MDBK cells to test additional members in the Flaviviridae: HCV in the hepacivirus genus and BVDV in pestivirus genus. As shown in Figures 2A-2D , all of these viruses require TMEM41B for infection. This demonstrates that TMEM41B is a pan-flavivirus host factor.

Flaviviruses replicate in a variety of tissue types. Therefore, we generated TMEM41B KO and reconstituted cell clones in additional mammalian cell lines representing lung adenocarcinoma (A549) and placenta carcinoma (JEG3) epithelial cells. In addition, we knocked out and reconstituted the mosquito TMEM41B ortholog in C6/36 cells (Aedes albopictus) and Aag2 cells (Aedes aegypti) to determine if TMEM41B was necessary for flavivirus infection in the mosquito vector. We found that TMEM41B was required in nearly all virus-cell combinations (Figures 2E, S3A-S3G, and S4A-S4E). However, we observed several virus-cell combinations where TMEM41B appears to be less critical. For example, whereas TMEM41B is critical for YFV infection in HAP1, JEG3, and A549 cells, it is not required in Huh-7.5 cells.

Notably we even observed differences in the requirement for TMEM41B among two strains of the same virus: the WT Asibi strain of YFV and the 17D vaccine strain that differ by only 31 amino acids (Figures S3A and S3D) (dos Santos et al., 1995) . Given that VMP1 can compensate for TMEM41B deficiency, we hypothesized that differences in TMEM41B and VMP1 expression among cell types could potentially explain this variability. We therefore performed western blots on HAP1, JEG3, A549, and Huh-7.5 cell lysates to compare VMP1 and TMEM41B abundance. We found that full-length TMEM41B is highly expressed in HAP1 and JEG3 cells but is present at lower abundance in A549 and Huh-7.5 cells. Further, the TMEM41B antibody detects several abundant lower molecular weight bands in A549 cells that may or may not be TMEM41B isoforms. VMP1, in contrast, is expressed at lower levels in HAP1 cells compared to JEG3, A549, and Huh-7.5 cells ( Figure S4F ). While speculative, we posit that the differential requirement for TMEM41B that we observe in some virus-cell combinations is (C) and (D) dots represent the average of n = 3 replicates from individual single cell clones. Virus strain is indicated in the figure. Error bars in (A) and (B) show SD for n = 6 replicates. Error bars in (C) and (D) show SD for n = 3 replicates (WT) and individual KO clones. (E) due to differences in TMEM41B and VMP1 abundance and the extent to which VMP1 can compensate for TMEM41B deficiency.

Given that TMEM41B is broadly required among members of the Flaviviridae, we posited that other more distantly related viruses or unrelated viruses may share a similar requirement for TMEM41B. Using the TMEM41B KO and reconstituted HAP1 cells, we queried the TMEM41B requirement for a diverse panel of viruses including negative-and positive-sense RNA viruses, retroviruses, and DNA viruses. Interestingly, we found that Coxsackievirus 3B (CVB-3) infection is enhanced in the absence of TMEM41B, whereas infection with SARS-CoV-2, a member of the Coronaviridae, is impaired similar to the viruses in the Flaviviridae, suggesting that it also requires TMEM41B for infection. Aside from these two viruses, none of the other viruses tested were affected by the lack of TMEM41B ( Figures 2F-2I ). Our observation that SARS-CoV-2 requires TMEM41B for infection is supported by our recent coronavirus genome-wide CRISPR screening and validation results (Schneider et al., 2020) .

There are four reported TMEM41B isoforms in humans, however, only isoform 1 encodes a fully intact VTT domain. To determine if any of the other three isoforms can support flavivirus infection, we cloned and expressed each isoform in TMEM41B KO cells. Secondary structure predictions indicate that the first $47 amino acids of TMEM41B are unstructured (Kelley et al., 2015) . Therefore, we also generated a deletion mutant of isoform 1 lacking the first 47 amino acids. A diagram of these TMEM41B constructs is shown in Figure 3A . We found that only the full-length and N-terminal truncated isoform 1 proteins were able to fully support YFV and ZIKV infection in TMEM41B KO HAP1 cells; however, isoform 4, which contains half of the VTT domain, partially supported YFV infection ( Figure 3B ). From this we conclude that the TMEM41B VTT domain is required to support flavivirus infection whereas the N terminus is dispensable. It was reported that TMEM41B physically interacts with VMP1, raising the possibility that this interaction may be important for membrane remodeling in the early stages of autophagy (Morita et al., 2019) . Based on this we hypothesized that evolutionarily divergent TMEM41B orthologs may not support flavivirus infection in mammalian cells, given that there are extensive amino acid differences among the mosquito, tick, and human TMEM41B orthologs that may prohibit their interaction with human VMP1 (Ishii and Akira, 2005) ( Figure 3D ). To test if mosquito or tick TMEM41B orthologs could support flavivirus infection, we expressed TMEM41B orthologs from Aedes aegypti mosquitoes, Aedes albopictus mosquitoes, and Ixodes scapularis ticks in TMEM41B KO HAP1 cells and challenged them with YFV and ZIKV. To our surprise, we found that all three TMEM41B orthologs supported virus infection in mammalian cells (Figure 3C ). This suggests that despite amino acid differences, evolutionarily divergent TMEM41B orthologs can either functionally interact with human VMP1 or that a direct protein-protein interaction between TMEM41B and VMP1 is not required to support flavivirus infection.

Viruses and other pathogens have shaped human genetics over millennia. In the face of strong evolutionary pressure, naturally occurring single nucleotide polymorphisms (SNPs) can be enriched or purged from human populations. We investigated if any missense variants existed in human TMEM41B and found a SNP (rs78813996) at amino acid position 266 that results in an Ile266Val/Leu substitution with Val being the most prevalent variant. This SNP is nearly absent in European and African populations but is present at $3.5% frequency in the Latin American population and at a striking $20% frequency in the East and South East Asian population (https://www.ncbi.nlm.nih.gov/ snp/rs78813996) ( Figure 4A ).

We engineered these amino acid variants into a TMEM41B expression construct with a red fluorescent protein (tagRFP) fused to the N terminus. Western blot confirmed that both the tagRFP-TMEM41B WT and SNP I266L and I266V variants were expressed to similar levels in TMEM41B KO HAP1 cells ( Figures S5A and S5B ). We then challenged these cells with YFV and found that at 48 h post infection, the percent infection in cells expressing the I266L and I266V variants was reduced by 56% and 62% respectively, and that these cells produced >10-fold less virus as compared to cells expressing WT TMEM41B (Figures 4B and 4C) . Consistent with these results, ZIKV, DENV, and WNV infection rates decreased by 41%-67% in cells expressing the SNP variants, whereas the hPIV-3 control was unaffected ( Figure 4D ). These results suggest that naturally occurring variants in TMEM41B could potentially affect flavivirus pathogenesis in humans.

While culturing TMEM41B KO Huh-7.5 cells, we observed a striking visual accumulation of lipids. To confirm that these were lipid droplets, we stained WT and six independent TMEM41B KO Huh-7.5 clones with Nile red and found that in all clones, lipid droplets are considerably larger as compared to WT cells ( Figure 4E ). We then quantified this observation by measuring the area of individual droplets from a single imaging plane in at least 23 cells per clone and found that the average size of individual lipid droplets was up to 10 times larger among TMEM41B KO clones relative to WT cells ( Figure 4F ). Moretti et al. (2018) reported a similar observation in TMEM41B KO H4 neuroglioma cells, and it was later shown that these droplets contain neutral and sterol lipids (Kang et al., 2020) .

Having found that two naturally occurring TMEM41B variants, I266L and I266V, have a reduced capacity to support flavivirus infection, we next tested if these variants were able to rescue the enlarged lipid droplet phenotype. In addition to the two human variants, we also included the Aedes aegypti TMEM41B ortholog. As shown in Figure 4G , we found that expression of WT human and mosquito TMEM41B as well as the two human TMEM41B variants reduced the mean lipid droplets size to baseline. These results suggest that while these two SNPs negatively impact flavivirus infection, they appear to be fully functional in their ability to maintain normal lipid distribution as measured in this assay.

TMEM41B Co-localizes with Flavivirus NS4A and NS4B Proteins Next, we assayed whether the cellular localization of TMEM41B changed upon virus infection. We utilized the tagRFP-TMEM41B expression construct to monitor TMEM41B cellular localization prior to and during flavivirus infection. Previous imaging and proteomics experiments have shown that TMEM41B localizes to ER membranes (Moretti et al., 2018; Morita et al., 2019) . Our observations in TMEM41B KO HAP1 cells expressing tagRFP-TMEM41B are consistent with ER localization. Interestingly, upon infection with either YFV or ZIKV, we observed a striking re-localization of tagRFP-TMEM41B from a diffuse reticularlike pattern to a large cytosolic aggregate that co-localized with viral nonstructural proteins, NS4A (ZIKV) and NS4B (YFV) ( Figure 5A ). This is consistent with a previous report that found ZIKV NS4B interacts with TMEM41B (Scaturro et al., 2018) . NS4A and NS4B are multipass transmembrane proteins known to induce membrane curvature, which, together with additional nonstructural viral and likely host proteins, form the viral RNA replication complex.

To further confirm that TMEM41B co-localizes with NS4A and NS4B, we performed co-immunoprecipitation experiments using an anti-RFP antibody to immunoprecipitate tagRFP-TMEM41B. We found that NS4A in lysates from ZIKV-infected cells and NS4B in lysates from YFV-infected cells co-immunoprecipitated with tagRFP-TMEM41B, whereas NS4A or NS4B was not detected in immunoprecipitates from lysates from uninfected cells or infected cell lysates immunoprecipitated with an immunoglobulin G (IgG) isotype control antibody (Figures 5B and 5C). We probed these blots for b-actin to confirm that similar (B) , and supernatants were collected and titrated by tissue culture infectious dose (TCID 50 /mL) assay on Huh-7.5 cells. The two-tailed statistical Student's t test was used to determine statistical significance and is depicted with an asterisk indicating a p value < 0.05. (D) Same as (B) infected with ZIKV, DENV-GFP, WNV-GFP, and hPIV-3-GFP. (E) WT and TMEM41B KO Huh-7.5 cell clones stained with Nile red to visualize lipid droplets. (F) Cumulative frequency of droplets plotted versus droplet area (mm 2 ) for six independent single-cell clones generated with two independent sgRNAs. Inset shows the mean lipid droplet area (mm 2 ) for the six TMEM41B KO clones compared to WT Huh-7.5 cells. (G) Mean lipid droplet area (mm 2 ) for WT, TMEM41B KO, and TMEM41B KO Huh-7.5 cells (clone 1-1) expressing the indicated TMEM41B variants. Cells were analyzed by flow cytometry and plotted as a percentage of viral antigen positive cells. Error bars depict SD for n = 3 replicates. ll amounts of lysate were used as input, and we probed for RFP to confirm that equal amounts of tagRFP-TMEM41B were immunoprecipitated in both uninfected and infected cells (Figures S6A and S6B) . All together, these results suggest that TMEM41B is recruited to sites of viral RNA replication either indirectly or potentially by direct interaction with NS4A and/or NS4B.

Viruses exist as diverse populations of variants and can readily adapt to new environments. These genetic adaptations can highlight viral proteins or viral RNA structures that are under selective pressure in a given context. Throughout our experiments, we observed rare YFV and ZIKV antigen-positive cells after infecting clonal TMEM41B KO populations. To gain potential insight into which stage of the virus replication cycle was affected by the absence of TMEM41B, we sought to capitalize on these rare infection events to select for adaptive mutations within the viral genome. We did this by serial passaging of ZIKV-infected cells and culture supernatants to select viral variants capable of replicating in TMEM41B-deficient cells. We performed virus supernatant passaging experiments in human TMEM41B KO A549 and HAP1 cells, and in parallel, we passaged ZIKV-infected TMEM41B KO mosquito Aag2 cells. Serial passages were performed in multiple independent lineages for each cell type, and we similarly passaged virus in WT cells to control for cell culture adaptive mutations that arise, which are unrelated to TMEM41B KO. Figure 6A shows a graphical outline of these experiments. After 15-20 rounds of passaging, we deep-sequenced viral cDNA from cell supernatants to identify viral variants that were enriched in virus populations passaged in TMEM41B KO cells relative to virus populations passaged in WT cells. To qualify as a potential adaptive mutation, we applied a stringency filter that required mutations to be present in at least three independent passages (regardless of cell type) and not present in virus that had been passaged in WT cells. Remarkably, all mutations that met these criteria were located in NS4A and NS4B. Further, NS4B mutations at positions Ile42 and Ser236 were selected in both mosquito and mammalian cells ( Figure 6B ).

To confirm that these mutations we selected enable ZIKV to infect TMEM41B-deficient cells, we chose to introduce two mutations in NS4B, Ile42Thr and Phe91Tyr, into the infectious cDNA clone of the Cambodian ZIKV strain FSS13025 (Shan et al., 2016) and generated viral stocks. Figures Article deficiency in A549 cells. The live-attenuated YFV 17D vaccine strain differs from the parental Asibi strain by only 31 amino acids, three of which are located within NS4A (V107I) and NS4B (M95I and Y232H) (dos Santos et al., 1995) . Given the strain-specific differences we observed in TMEM41B KO A549 cells, together with the observation that single amino acid changes in NS4B could allow flavivirus replication in TMEM41B KO cells, we next generated 17D:Asibi chimeric viruses by swapping NS4A and NS4B individually or by swapping the region containing both NS4A and NS4B, which includes the 2K protein.

Remarkably, we found that in the 17D viral background, NS4B from the Asibi strain significantly increased infection in TMEM41B KO A549 cells, whereas the NS4B from the 17D strain slightly decreased the infectivity of the Asibi strain in TMEM41B KO cells. In contrast, the NS4A changes had no impact on infection. Importantly, parallel infections in WT A549 cells show that the results observed in the KO cells are not due to an overall increase or decrease in viral replication but rather were likely due to a differential requirement for TMEM41B in this cellular context ( Figures 6E and 6F ). In the absence of TMEM41B, viral RNA replication may initiate in aberrant replication complexes that are exposed to the cytosol. This hypothesis assumes that TMEM41B is required for viral RNA replication, not virus entry. To test this, we transfected WT and TMEM41B KO HAP1 cells with a YFV Renilla reniformis luciferase (Rluc) reporter subgenomic replicon (Jones et al., 2005) to bypass the entry step, and we measured Rluc over a time course. Indeed, results in Figure S7A confirm that the transfected RNA is translated, but RNA replication is severely impaired. While this does not entirely rule out a role for TMEM41B in virus entry, it nevertheless provides concrete evidence that TMEM41B is required for virus RNA replication.

We next tested if the cytotoxicity we observed in TMEM41B KO HAP1 cells upon infection with a virus inoculum sufficient to infect most cells during the initial infection was due to innate immune activation. For this, we inoculated WT and TMEM41B KO HAP1 cells with YFV 17D virus (MOI = 0.4 PFU/cell), then quantified viral RNA and mRNA encoding 2 0 -5 0 -oligoadenylate synthetase 1 (OAS1) by qPCR at 24 h post infection. OAS1 is a classic interferon (IFN)-stimulated gene (ISG) induced by type I and III IFNs. As shown in Figure 7A , we found that YFV 17D RNA levels were 100-fold lower in TMEM41B KO cells compared to WT cells, consistent with an inability to replicate; however, OAS1 was highly induced in the KO cells but not induced in WT cells (Figure 7B, left) . To determine if OAS1 induction was due to the virus itself or functional viral RNA, we inoculated both WT and TMEM41B KO cells with viral particles inactivated by UV light. UV-inactivated virus failed to induce OAS1 expression in both cell lines suggesting that viral protein production and perhaps initiation of viral RNA replication was required to induce innate immunity (Figure 7B, middle) . To control for the possibility that TMEM41B KO cells are hypersensitive to PAMPs in general, we infected both WT and TMEM41B KO cells with a recombinant influenza A virus (IAV) lacking a critical innate immune antagonist protein, NS1 (IAV DNS1). This virus is well known for its defect in antagonizing IFN production and ISG expression (García-Sastre et al., 1998; Wang et al., 2000) . We found that both WT and TMEM41B KO responded to IAV DNS1 as expected, with WT cells expressing even slightly higher amounts of OAS1 mRNA than TMEM41B KO cells (Figure 7B, right) .

Upon detection of viral PAMPs, cells secrete IFN to protect neighboring cells from infection then subsequently initiate apoptosis (Drappier and Michiels, 2015; Gusho et al., 2020; Schwartz and Conn, 2019) . To assay if apoptosis explained the cytotoxicity we observed in TMEM41B KO cells after virus inoculation, we infected WT and TMEM41B KO cells with YFV 17D (MOI = 4 PFU/cell) and quantified the number of apoptotic cells at 24 h post inoculation. As shown in Figure 7C , we observed an approximate 3-fold increase in the percentage of apoptotic cells in TMEM41B KO cells compared to WT cells. Importantly, at this time point, there was almost no increase in the percentage of apoptotic cells in the infected WT cell population as compared to mock-infected cultures. Further, the positive control, passaged in WT cells are shown. Boxes show the number of replicates a mutation was identified over the total number of replicates. Of six initial replicates for the A549 TMEM41B KO clones, only five were maintained for 20 passages. (C) I42T and F91Y mutations were independently engineered in a ZIKV infectious clone to generate virus stocks to infect WT (left) or TMEM41B KO (right) Aag2 cells. (D) Same as (C) in WT and TMEM41B KO A549 cells. (E and F) WT and TMEM41B KO A549 cells infected with YFV 17D and Asibi chimeric viruses. (E) 17D backbone with Asibi NS4A and NS4B proteins; (F) Asibi backbone with 17D NS4A and NS4B proteins. Cells were analyzed by flow cytometry and plotted as a percentage of viral antigen positive cells. Error bars depict SD for n = 3 replicates.

Cell 184, 133-148, January 7, 2021 143 staurosporine (STS), induced apoptosis in approximately 70% of the cells, with no notable difference between WT and TMEM41B KO cells ( Figure 7C ).

We next sought to test if the enhanced innate immune activation in response to flavivirus infection in TMEM41B-deficient cells could explain the block in virus infection. For this, we utilized inhibitors targeting TBK1 and JAK proteins to block IFN production and signaling, respectively. We found that while the presence of these inhibitors increased infection frequency of YFV-17D and ZIKV in WT cells, they were unable to rescue infection in TMEM41B KO cells (Figures S7B and S7C ). Together, these data suggest that sensing dsRNA and innate immune activation is a consequence of TMEM41B-deficiency, but innate immune activation does not fully explain the block in flavivirus replication.

Genome-wide CRISPR-Cas9 gene disruption screens are a powerful method of discovery. We applied this method to discover cellular host factors that flaviviruses require to replicate in human cells. As a testament to the robustness of this approach, our results along with CRISPR-Cas9 screens performed by several other research groups identified shared genes and biological pathways. Screens, however, are often only the first step toward understanding new virus-host biology.

In our follow-up studies, we found that all flaviviruses we tested, including both mosquito-borne and tick-borne flaviviruses, required TMEM41B for infection and replication. Further, we found that TMEM41B was required in the mosquito vector ll as well, supporting a conserved role for TMEM41B in flavivirus infection in distantly related species. Given that TMEM41B is required for flavivirus infection and that TMEM41B is also required for autophagy, the question arose: is autophagy required for flavivirus infection? Our results suggest that under the conditions we tested, the full autophagy pathway is not essential for flavivirus infection. This led us to hypothesize that flaviviruses may hijack TMEM41B and VMP1 for their ability to remodel host cell membranes-a feature required both for autophagy and for the formation of viral replication complexes.

Although every flavivirus we tested required TMEM41B in most cell types, there were several virus-cell combinations we tested where TMEM41B was either not required or played a less essential role in virus infection. This conundrum may be explained by cell-type-specific differences in the abundance of related cellular host proteins such as VMP1 and TMEM41A, which we found can partially support flavivirus infection in the absence of TMEM41B. These findings suggest that TMEM41B may be an important cellular determinant that defines flavivirus tissue tropism and pathogenesis. Along these lines, it is notable that a SNP in TMEM41B present in approximately 20% of East and South East Asian and 3.5% of Latin American populations has a reduced capacity to support flavivirus infection. While it is impossible to know for sure what drove selection of this SNP in these populations, it is conceivable that a pathogenic flavivirus may have been involved.

While variations in the host environment can influence virus tropism, so too can variations in the virus. Our studies uncovered that two highly related YFVs, the virulent Asibi strain and the live attenuated 17D vaccine strain, displayed a differential ability to infect JEG3 and A549 cells lacking TMEM41B. The fact that the YFV Asibi and 17D strains differ by only 31 amino acids provided us with an opportunity to investigate the flavivirus TMEM41B dependency down to the level of an individual viral protein.

Our results indicate that amino acid differences in NS4A and NS4B between these two strains may be responsible for their differential TMEM41B requirement. Future studies are needed to better understand how single amino acid changes in NS4B (and possibly NS4A) bypass the strong TMEM41B requirement during flavivirus infection. Together these results highlight plasticity even among ''essential'' host factors and demonstrate that loss of a critical host factor can be overcome by relatively few genetic changes in the viral genome. This contrasts the notion that resistance barriers may be higher when targeting host factors with antiviral therapeutics as opposed to targeting the virus. When dealing with highly diverse viral populations, multi-target drug cocktails are still likely to be important regardless of whether therapies target host or viral factors.

Our final observation where we demonstrate that TMEM41B cells initiate a strong innate immune response when exposed to a large number of virus particles provides mechanistic insights into the role of TMEM41B in the flavivirus replication cycle. Based on our collective results we propose a model, shown in Figure 7D , where upon flavivirus infection and translation of the viral polyprotein, TMEM41B is recruited to sites on the ER membrane together with NS4A and NS4B where replication complexes are forming (Neufeldt et al., 2018; Paul and Bartenschlager, 2015) . This recruitment may be through direct pro-tein:protein interaction or through passive diffusion, where, by mobilizing neutral and sterol lipids, TMEM41B helps lower the local free energy imposed by NS4A-and NS4B-induced membrane curvature. We propose that TMEM41B's role in facilitating membrane curvature is dependent upon a functional interaction between TMEM41B and VMP1, the latter of which is highly mobile and associates with cell organelles, vesicles, and lipid droplets (Tá bara and Escalante, 2016; Zhao et al., 2017) . In the absence of TMEM41B, flavivirus NS4A and NS4B proteins (which may or may not be fully processed) assemble and viral RNA replication initiates, but because replication complexes are improperly formed, dsRNA intermediates are exposed to pattern recognition receptors (PRRs). At this point, the infectious replication cycle is aborted because the RNA genome cannot be efficiently copied and the low level of replication that initiates activates innate immune pathways.

Lastly, we and others recently identified TMEM41B as a top scoring hit in genome-wide CRISPR-Cas9 loss-of-function screens designed to identify coronavirus host dependency factors (Baggen et al., 2020; Wang et al., 2020 and accompanying manuscript: Schneider et al., 2020) . It will be fascinating to learn if TMEM41B is also required to assemble coronavirus replication complexes. In conclusion, TMEM41B may be a candidate target to inhibit the replication of a broad range of emerging and re-emerging flavivirus and coronavirus pathogens.

Detailed methods are provided in the online version of this paper and include the following: 

We thank the following investigators for contributing viral molecular clones and viral stocks: P. Hearing Zhao, Y.G., Chen, Y., Miao, G., Zhao, H., Qu, W., Li, D., Wang, Z., Liu, N., Li, L., Chen, S., et al. (2017 polyclonal antibody B224 (kindly provided by Kenny V. Brock, Auburn University; 1:500), rabbit anti-tagRFP (see above) and normal rabbit IgG (Cell Signaling Technology: 2729; RRID: AB_1031062). Secondary antibodies, proteins and staining solutions used for IF, flow cytometry and IP include goat anti-rabbit IgG conjugated to HRP (ThermoFisher Scientific: 31462; RRID: AB_228338; 1:5,000), goat anti-mouse IgG conjugated to HRP (Jackson ImmunoResearch Labs: 115-035-146; RRID: AB_2307392; 1:10,000), goat anti-bovine IgG conjugated to FITC (ThermoFisher Scientific: A18752; RRID: AB_2535529; 1:1,000), goat anti-mouse IgG conjugated to AF647 (ThermoFisher Scientific: A-21235; RRID: AB_2535804; 1:1,000), goat anti-mouse IgG conjugated to AF488 (ThermoFisher Scientific: A-11001; RRID: AB_2534069; 1:1,000), goat anti-rabbit IgG conjugated to AF488 (ThermoFisher Scientific: A-11008; RRID: AB_143165; 1:2,000) and Protein A-HRP (ThermoFisher Scientific: 10-1023) . Hoechst 33342 solution (ThermoFisher Scientific: 62249) was used at 1 mg/mL for nuclear stain. Nile Red Staining Kit (Abcam: ab228553) was used according to the manufacturer's instructions to stain for intracellular lipid droplets.

Drugs 

All ORFs were cloned into a modified pTRIPZ vector for lentivirus delivery to cells. All plasmid sequences are available upon request. Lentivirus stocks were generated in Lenti-X 293T cells by co-transfection of plasmids expressing (1) the ORF of interest (2), HIV gag-pol, and (3) the vesicular stomatitis virus glycoprotein (VSV-G) in a ratio of 0.55:0.35:0.1 using Lipofectamine 2000 Transfection Reagent (ThermoFisher Scientific: 11668030) at a ratio of 2.5 ml reagent to 1 mg DNA. One day prior to transfection, cells were seeded at 4 3 10 5 cells per well of poly-L-lysine coated 6-well plates. Cells were transfected the following day and six h post transfection media was removed and lentivirus was collected overnight in 2 mL per well. Supernatants were collected at 24 and 48 h, filtered using 0.45-micron syringe filters, and stored at À80 C.

For lentiviral transduction, 3 3 10 5 cells were transferred to 12-well plates in suspension and transduced with several lentivirus dilutions by spinoculation at 1,000 x g for 60 min at 37 C in medium containing 3% FBS, 20 mM HEPES, and 4 mg/mL polybrene. The following day cells were trypsinized and moved to duplicate wells of 6-well plates. At approximately 48 h post transduction one well of each duplicate was selected with 2 mg/mL puromycin. When selection was complete, the selected and unselected replicates were counted to determine approximate MOI and we proceeded to expand cells that were transduced at MOI < 0.3 to ensure that most cells in the population contained a single integrant. The pTRIPZ constructs are doxycycline inducible and all experiments with these constructs were performed after 24 h of pretreatment and in the continued presence of 2 mg/mL doxycycline.

Mammalian cells Small guide RNAs (sgRNA) for CRISPR editing were designed using crispor.tefor.net (Haeussler et al., 2016) and cloned into lenti-CRISPRv2 plasmid CRISPR KO clones were generated by transfection with the relevant guides, selected with 2 mg/mL puromycin for four days prior to single-cell seeding into 96-well plates in the absence of puromycin at a dilution of 0.7 cells/well to obtain singlecell clonal populations. Clones were expanded and screened for protein knockout by western blot analysis or sequencing analysis. Genomic DNA was extracted using the QIAGEN DNeasy Blood and Tissue Kit (QIAGEN: 69504) and used as a template for amplification of an approximately 500-1,000 bp region flanking the PAM site. Discrete bands were gel-extracted and gene disruption was confirmed by submitting samples to the CCIB DNA Core Facility, Massachusetts General Hospital (Cambridge, MA, USA) for high throughput amplicon sequencing.

We used the following sgRNAs in these studies. sgRNAs targeting TMEM41B in HAP1, A549, JEG3, and Huh-7.5 cells: sgRNA 1: 5 0 -GTCGCCGAACGATCGCAGTT À3 0 and sgRNA 2: 5 0 -GCTCACCACACGACCCCCGT À3 0 . sgRNA targeting TMEM41B in MDBK cells: 5 0 -ATACTGAGAAATATAGAGCC À3 0 . sgRNA targeting TMEM64 in HAP1 cells: 5¿-GCTCCAGATAGGCGCCGAGC À3¿. sgRNA targeting TMEM41A in HAP1 cells: 5 0 -TCGCGTCGACAGCAAGTACA À3 0 . sgRNA targeting VMP1 in HAP1 cells: 5 0 -GCTC TGGCCATGAAATATGG À3 0 . sgRNA targeting ATG5 in HAP1 cells: 5 0 -TTCCATGAGTTTCCGATTGA À3 0 . sgRNA targeting ATG7 in HAP1 cells: 5 0 -CCTAGCTACATTGCAACCCA À3 0 . sgRNA targeting BECN1 in HAP1 cells: 5 0 -CCTGGATGGTGACACGGTCC À3 0 . All oligos were purchased from IDT. Mosquito cells CRISPR/Cas9 plasmids were generated from the pDDC6 vector, which encodes the human codon-optimized Streptococcus pyogenes Cas9 (hSpCas9; a gift from Peter Duchek) (Addgene plasmid: #59985; http://n2t.net/addgene:59985; RRID: Addg-ene_59985). For expression in mosquito cells, we replaced the dme phsp70 promoter (hsp70Bb) in pDCC6 with the Ae. aegypti polyubiquitin promoter (aae PUb) and we replaced the dme U6-2 promoter with the Ae. aegypti U6 promoter (aae U6; AAEL017774). We also added a selectable puromycin resistance cassette to the hSpCas9. Plasmid sequence is available from Addgene (plasmid #162163). The following sgRNAs were cloned into the abovementioned plasmid. sgRNAs targeting TMEM41B ortholog (AAEL022930-RB) in Aag2 cells: 5 0 -CAAAGATCTCTACTACCTGG À3 0 and 5 0 -TATGTAGACGAGGACCACGC À3 0 . sgRNAs targeting TMEM41B ortholog (AALF002881-RA) in C6/36 cells: 5'-CAAACAGTTGGGACGAGTGC À3 0 and 5 0 -TGTAGCTGAGGAGGTCTTCC À3 0 . All oligos were purchased from IDT. Cells were transfected with the appropriate plasmids using Fugene HD Transfection Reagent (Promega: E2311) according to the manufacturer's protocol. Cells were seeded at $50% confluency and complexes were formed using a ratio of 3:1 transfection reagent to plasmid DNA. To generate single cell clones, cells were seeded in 96-well plates ($0.7 cells/well) in 50% fresh media, and 50% conditioned media and expanded. Gene disruption was confirmed by high throughput amplicon sequencing and described above. For additional details please see (Rozen-Gagnon et al., 2020) . . LV-GFP was generated in Lenti-X 293T as described above. CVB-3-GFP (Feuer et al., 2002) (derived from infectious clone pMKS1-GFP) was amplified in HeLa cells and titrated by TCID 50 . SARS-CoV-2 (WA1/2020 obtained from BEI Resources) and ZIKV (PRVABC59 obtained from the CDC, Ft. Collins) were amplified in Huh-7.5 and HAP1 cells respectively and titrated by standard plaque assay on Huh-7.5 cells. YF viruses (17D and Asibi) and the Cambodian ZIKV (Shan et al., 2016) (strain: FSS13025, generously provided by Pei-Yong Shi) were generated from infectious clones as described below. Experiments with YFV (strain: Asibi), WNV-GFP, CHIKV-GFP and SARS-CoV-2 were carried out in biosafety level 3 (BSL3) containment in compliance with institutional and federal guidelines. The tick-borne viruses POWV (strain: Byers, VSPB 812027), TBEV (strain: Hypr, VSPB 812222 and Sofjin, VSPB 812223), OHFV (strain: Bogoluvovska, VSPB 812005), KFDV (strain: P9605, VSPB 811996) and AHFV (strain: 200300001, VSPB 200300001) were generated at the CDC and experiments were carried out in BSL4 containment in compliance with institutional and federal guidelines (Flint et al., 2014; Zaki, 1997) .

Recombinant viruses for the Cambodian ZIKV (strain: FSS13025), the YFV vaccine strain 17D and wildtype Asibi strain, as well as the YF chimeric 17D and Asibi viruses were generated using plasmids encoding the infectious clones. To generate mutant and chimeric viruses, overlapping oligos were created to either introduce point mutations or to allow the amplification of specific coding sequences. PCR reactions were run under standard conditions using KOD Hot Start Master Mix (Sigma-Aldrich: 71842). After subsequent ligation with T4 ligase (NEB: M0202), the plasmid DNA was amplified in competent DH5-ɑ E.coli cells (ThermoFisher Scientific: 18265017). All plasmids encoding WT and mutant/chimeric viruses were sequenced for the absence of unwanted mutations within the viral coding region. For in vitro transcription, 2 mg linearized plasmid DNA was used in a 30 ml reaction with the mMessage mMachine SP6 Transcription Kit (ThermoFisher Scientific: AM1340). RNA integrity was examined by electrophoresis on a 1% agarose gel. Huh-7.5 cells were subsequently electroporated with 4 mg of YFV RNA mixed into 6 3 10 6 cells, while C6/36 cells were used for electroporating ZIKV RNA under similar conditions. Electroporated cells were incubated for 48-72 h before collecting and titrating supernatants by standard plaque assay in Huh-7.5 cells.

All virus infections and quantification were performed using the doses and time points reported in the figure legends and below for quantification by flow cytometry or microscopy. For infections, cells were seeded at a density of 1 3 10 4 cells/well into black, glassbottom 96-well plates (PerkinElmer: 6055302) and at 2.5 3 10 4 -5 3 10 4 cells/well into regular tissue culture 24-well plates. The next day, cells were washed 1x with Opti-MEM (GIBCO) and adsorbed with virus inoculum (50 ml for 96-well and 200 ml for 24-well plates) prepared in Opti-MEM at 37 C. After 1-2 h inoculum was removed, cells were washed with Opti-MEM, fresh media was added, and cells were incubated at 37 C. At the final time point dependent on viral replication kinetics, cells in 24-well plates were lifted with Accumax cell dissociation medium (Sigma: A7089) and fixed with 2% paraformaldehyde (PFA). Cells infected with GFP/RFP reporter viruses were pelleted at 930 x g for 5 min at 4 C, resuspended in cold phosphate-buffered saline (PBS) containing 3% FBS and stored at 4 C until analysis using a LSRII flow cytometer (BD Biosciences). FlowJo software v10 (Treestar) was used to obtain the percentage of GFP/RFP-expressing cells, which were graphed using Prism8 (Graphpad) .

For non-fluorescent reporter viruses, cells were washed 1x in PBS (+ 2% FBS), permeabilized in 1x BD perm (BD Biosciences: 554723) for 1 h at RT followed by overnight incubation with primary antibody. Cells were then washed three times with BD perm, incubated with secondary antibody for 1 h at RT, washed an additional three times with BD perm, and once with PBS (+ 2% FBS) before being transferred to FACS tubes for flow-cytometry analysis similar as for aforementioned reporter viruses.

Cells infected in 96-well plates were fixed with 10% neutral-buffered formalin, permeabilized with 0.1% Triton X-100 in PBS for 10 min at RT, washed in PBS with 0.01% Tween20 (PBS-T) and incubated with primary antibody (pan-flavivirus HMAF) overnight. The secondary antibody was used at RT for 1 h together with NucBlue (ThermoFisher Scientific: R37605) to stain for nuclei. Plates were subsequently read using the Perkin Elmer Operetta confocal high content imager with a 10x objective. Images were analyzed with a cell segmentation workflow using Harmony software v4.1 Perkin Elmer, Waltham, MA.

To determine sequences of ZIKVs passaged in mosquito (ZIKV strain: PRVABC59) and in mammalian WT and TMEM41B KO cells (ZIKV strain: FSS13025), RNA from 200 ml supernatants of each individual passage was purified by adding 800 ml TRIzol Reagent (ThermoFisher Scientific: 15596026) plus 200 ml chloroform then centrifuged at 12,000 g x 5 min. The upper aqueous phase was moved to a new tube and an equal volume of isopropanol was added. This was then added to an RNeasy mini kit column (QIAGEN: 74014) and further purified following the manufacturer's instructions. Viral RNA was reverse transcribed into cDNA using the Maxima H Minus First Strand cDNA Synthesis Kit (ThermoFisher Scientific: K1681) according to the manufacturer's protocol, amplified using ZIKV-specific primers (available upon request) and submitted to the CCIB DNA Core Facility, Massachusetts General Hospital (Cambridge, MA, USA) for high throughput amplicon sequencing. Briefly, samples were sheared, ligated to Illumina compatible adapters with unique barcodes, and sequenced from both ends on the MiSeq platform with 2x150 run parameters.

Unless otherwise described, cells were fixed in 2% PFA prepared in PBS at RT for 10 min. Cells were then directly stained for intracellular lipid droplets using the Nile Red Staining Kit (Abcam: ab228553) according to the manufacturer's instructions, or Figure 5 from ZIKV-infected lysates. Left panel was probed with b-actin to show that similar amounts of whole cell lysate were used as input. Right panel was probed with anti-RFP to show that similar amounts of RFP-TMEM41B were immunoprecipitated from mock and infected lysates but not when using an IgG control antibody. (B) Same as (A) with YFV-infected cells. Of note, the b-actin signal detected in the anti-RFP IgG immunopreciptated fraction is likely an unspecific interaction with the RFP or with TMEM41B as it has been shown that the cytoskeleton (e.g., actins) can interact with organelles (e.g., ER). as the transfected RNA is translated. Rluc signal declines between 4 and 12 h as the transfected RNA decays (dDD) or is removed from the translating pool to serve as template for viral RNA replication. Rluc signal increases in WT cells transfected with WT replicon RNA, whereas the signal is dramatically reduced in TMEM41B-deficient cells. (B and C) WT and TMEM41B KO A549 cells infected with (B) YFV 17D, MOI = 0.025 PFU/cell for 48 h and (C) ZIKV, MOI = 0.05 PFU/cell for 48 h in the presence or absence of innate immune inhibitors. Cells were treated with 500 nM TBK1 and pan-JAK inhibitors or vehicle control (0.05% DMSO) 24 h prior to infection and throughout the experiment. The percentage of infected cells increases in WT cells in the presence of TBK1/JAK inhibitors, but not in TMEM41B KO cells. sg #1 and sg #2 indicates KO clones generated using TMEM41B sgRNA1 and sgRNA2, respectively. Two KO clones were used in each experiment as indicated in the figure. WT and KO clones were assayed in triplicate. Individual dots represent the average of the triplicates and error bars show the standard deviation of results from the average of the KO clones. ll Article

HeLa cells (human; sex: female, cervix epithelial), VeroE6 cells (Chlorocebus sabaeus; sex: female, kidney epithelial), BSC-40 cells (Chlorocebus aethiops; sex: unspecified, kidney epithelial), BHK-21 cells (Mesocricetus auratus; sex: unspecified, kidney fibroblasts) and MDBK cells (bovine; sex: male, kidney epithelial) were cultured in Dulbecco's Modified Eagle Medium (DMEM, GIBCO) supplemented to contain 10% FBS (or 10% horse serum [ThermoFisher Scientific] in case of MDBK cells) and 1% NEAA. All mammalian cell lines were obtained from the ATCC unless stated otherwise, cultured at 37 C and incubated with 5% CO 2 . Mosquito C6/36 (Ae. albopictus, sex: unspecified, neonate larva) and Aag2 (Ae. aegypti, sex: unspecified, neonate larva) cells were obtained from ATCC and Dr. Maria-Carla Saleh, respectively. Cells were cultured in Leibovitz's L-15 Medium

Genome-wide CRISPR-Cas9 Knockout Screen HAP1 B3GALT6 KO-Cas9 cells were generated by lentiviral transduction of lentiCas9-Blast, a gift from Feng Zhang

The human GeCKO library (A and B) (Shalem et al., 2014) was a gift from Feng Zhang and obtained through Addgene (cat. #1000000049). The plasmid was expanded and lentivirus was produced as previously described

To produce lentivirus, each A and B half-library was pooled 1:1, then transiently transfected into HEK293T/17 cells in 20 3 15 cm 2 dishes. Transfection conditions were 5.4 mg library pool, 3.6 mg psPAX2, 1.8 mg pMD2.G and 21.6 mg branched polyethylenimine (PEI) transfection reagent (MilliporeSigma: 408727) per plate. Media was changed 16 h post-transfection. Lentiviral supernatants were collected, passed through a 0.45 mm Stericup PVDF filter (Millipore), concentrated by ultracentrifugation at 100,000 x g for 2 h at 4 C and stored at À80 C. To deliver the GeCKO (A and B) sgRNA library to cells

We seeded cells at 3.5 3 10 6 cells per T175 flask and we seeded 15 flasks per replicate (in triplicate) for each virus infection as well as Mock. The following day, the media was removed, and viruses diluted in 10 mL/flask OptiMEM were added to cells. ZIKV was added at MOI = 0.025 PFU/cell and YFV Asibi was added at MOI = 0.5 PFU/cell

All PCRs were performed using Herculase II Fusion DNA polymerase with manufacturer recommended cycling parameters using 5 mg gDNA per 50 mL reaction volume (Agilent: 600679). After PCR1, PCR products were purified using QIAquick PCR Purification Kit (QIAGEN: 8104) and used as a template for PCR2 to add Illumina sequencing adapters and indexes. PCR products were agarose gel purified

Antibodies and Chemicals Primary antibodies used for western blot include rabbit anti-TMEM41A

Abcam: ab192890; RRID: AB_2827794; 1:2,000), rabbit anti-tagRFP (Evrogen: AB233; RRID: AB_2571743; 1:1,000) and mouse anti-b-actin conjugated to HRP (Sigma-Aldrich: A3854; RRID: AB_262011; 1:50,000)

Related to Figure 1: For ZIKV infections in HAP1 cells comparing WT versus VTT domain protein KO clones and BECN1, ATG5, and ATG7 KO clones, cells were infected for 48 h at MOI = 0.5 PFU/cell. For ZIKV infections in HAP1 cells comparing WT versus TMEM41B KO or VMP1 KO cells expressing VTT domain proteins, cells were infected for 48 h at MOI = 0.25 PFU/cell. Similar experiments with YFV Asibi were performed with MOI = 0.1 PFU/cell for 72 h. Related to Figure 2: WT and TMEM41B KO HAP1 cells were infected with POWV for 48 h at MOI = 0.02 PFU/cell. All other tickborne flaviviruses, including TBEV strains Hypr and Sofjin, OHFV, KFDV, and AHFV were inoculated at MOI = 0.02 PFU/cell and harvested at 24 h post infection. WT and TMEM41B KO Huh-7.5 clones were infected with HCV-RFP for 72 h at MOI = 0.05 PFU/cell. WT and TMEM41B KO MDBK clones were infected with BVDV for 48 h at MOI = 0.01 PFU/cell. WT, TMEM41B KO and reconstituted HAP1 cells were

Related to Figure 3: WT, TMEM41B KO, and TMEM41B KO cells expressing human TMEM41B isoforms or mosquito and tick TMEM41B orthologs were infected with YFV Asibi at MOI = 0.1 PFU/cell for 72 h, or ZIKV at MOI = 0.25 PFU/cell for 48 h. TMEM41B isoforms are as follows: Isoform 1, UniProt ID: Q5BJD5-1; isoform 2, UniProt ID: Q5BJD5-2; isoform 3, UniProt ID: Q5BJD5-3; isoform 4, UniProt ID: E9PJ42. Related to Figure 4: WT, TMEM41B KO, and TMEM41B KO HAP1 cells expressing WT or TMEM41B SNP variants were infected with YFV 17D at MOI = 0.005 PFU/cell for 48 h; ZIKV at MOI = 0.25 PFU/cell for 48 h; to Figure 5: TMEM41B KO HAP1 cells expressing RFP-TMEM41B were infected with YFV 17D at MOI = 1 and ZIKV at MOI = 2.5 PFU/cell for 24 h. Related to Figure 6: WT Aag2 (n = 1) and TMEM41B KO clones (n = 2) were infected with ZIKV (strain: PRVABC59) at MOI = 0.5 PFU/ cell in triplicate. Cells were passaged every 2-3 days for 15 passages after which supernatants were collected and viral RNA was reverse transcribed and sequenced with next generation sequencing (NGS). WT (n = 1) and TMEM41B KO A549 clones (n = 2) and WT (n = 1) and TMEM41B KO HAP1 clones (n = 2), were infected with ZIKV (strain: FSS13025) at MOI = 5 PFU/cell in triplicate

KO Aag2 cells at MOI = 0.001 PFU/cell for 72 h. WT and TMEM41B KO A549 cells were infected with WT and mutant viruses at MOI =

UV-inactivation) at MOI = 0.4 PFU/cell for 24 h. Cells were infected with IAV (DNS1) at MOI = 0.1 PFU/cell for 24 h. For apoptosis assay, WT and TMEM41B KO HAP1 cells were infected YFV 17D at MOI = 4 PFU/cell for 24 h or treated with 250 nM staurosporine (STS) and assayed to detect apoptotic cells via Annexin-V staining. were processed for antigen staining by blocking with PBTG (PBS containing 10% normal goat serum, 1% bovine serum albumin (BSA), 0.1% Triton X-100) at RT for 1-2 h. Cells were then incubated with primary antibodies diluted in PBTG (concentrations above) at 4 C overnight. Following four washes with PBS-T, cells were stained with AlexaFluor-conjugated secondary antibodies in PBTG at RT for 1 h. Following one wash with PBS-T, cells were incubated with Hoechst nuclear stain diluted in PBS at RT for 15 min, followed by three additional washes with PBS-T and a final wash with PBS. Images were acquired using a 40x oil immersion objective on an inverted Zeiss Axiovert 200 spinning disk confocal microscope using solid-state 491, 561 and 644 nm lasers (Spectral Applied) for excitation for collection with an Andor iXon 512x512 EMCCD camera using MetaMorph software

1% NP-40 with addition of cOmplete Mini EDTA-free protease inhibitor tablet [Millipore/Sigma: 11836170001]) and incubated on ice for 30 min with frequent vortexing and then clarified at 14,000 x g for 20 min at 4 C. Protein concentration was determined by bicinchoninic (BCA) protein assay (Pierce BCA Protein Assay Kit

Protein concentrations were determined by BCA assay as described above. Per sample, 50 mL (1.5 mg) Dynabeads Protein A for Immunoprecipitation (ThermoFisher Scientific: 10001D) were prepared and linked to 5 mg antibodies (rabbit anti-tagRFP and normal rabbit IgG control) according to the manufacture's protocol. 100 mg of whole cell lysate (WCL) were incubated with beads-antibody complexes for 70 min at RT followed by wash steps according to the manufacture's protocol. The resulting beads-antibody-antigen complexes were subsequently treated with elution buffer, mixed with NuPAGEâ LDS Sample Buffer (ThermoFisher Scientific: NP0008) and NuPAGEâ Sample Reducing Agent (ThermoFisher Scientific: NP0009) as per manufacturer's instructions and denatured for 15 min

ThermoFisher Scientific: AM1340) following the manufacturer's protocol and adding 1 ml of additional GTP. In vitro transcribed RNA was purified using the RNeasy Mini Kit (QIAGEN: 74104), examined for integrity by electrophoresis on a 1% agarose gel and quantified using a NanoDrop spectrophotometer. Next, HAP1 cells (WT, TMEM41B KO and tagRFP-TMEM41B reconstituted KO) were seeded into 24-well plates at 5 3 10 4 cells/well and incubated overnight at 37 C. The next day, 250 ng RNA/well of either WT or the polymerase dead (dDD) YFV replicon were transfected using Lipofectamine 2000 Transfection Reagent (ThermoFisher Scientific: 11668030) at a ratio of 2.5:1 ml transfection reagent to mg RNA. Cells were harvested at indicated time points by washing 1x with 250 ml PBS, adding 150 ml of diluted 5x Passive Lysis Buffer (Promega: E1941), incubating for 20 min at RT and storing lysates at À20 C. Samples harvested at different time points were processed together using the Dual-Luciferaseâ Reporter Assay System (Promega: E1910) and a FLUOstar Omega multimode microplate reader

After 24 h, detached cells (from supernatant and PBS wash) together with the trypsinized cells were harvested into tubes and samples were prepared on ice for flow cytometry using the Pacific Blue Annexin V Apoptosis Detection Kit with 7-AAD (Biolegend: 640926) according to the manufacturer's protocol. Cells were subsequently washed twice in binding buffer, followed by fixation in 2% PFA in PBS before subjecting them to flow cytometry using the LSR-II (BD Biosciences). Data was analyzed by FlowJo v10 and graphed by Prism 8 (GraphPad). ISG response HAP1 WT and TMEM41B KO cells were seeded into 24-well plates at 7.5 3 10 4 cells/well. The next day, cells were infected with the YFV vaccine strain 17D, UV-inactivated YFV 17D and IAV (DNS1) diluted in Opti-MEM for 2 h at 37 C. After 2 h cells were washed with Opti-MEM before adding fresh culture medium

Z-scores were computed using the following approach: for each condition, the log2 fold change with respect to the initial condition was computed. A natural cubic spline with 4 degrees of freedom was fit to each pair of infected and control cells and residuals were extracted. To obtain gene-wise data, the mean residuals for each group of sgRNAs was calculated, a z-score was computed, and a p value was determined using a 2-sided normal distribution test. P values were combined across biological replicates using Fisher's sumlog approach and corrected for multiple testing using the method of Benjamini & Hochberg. Analysis of lipid droplets in WT versus TMEM41B KO cells Upon staining intracellular lipid droplets using Nile red, images were analyzed using Fiji software (Schindelin et al., 2012) as follows: A maximum z-projection was made from the acquired image stacks, and the particles were identified through a fixed threshold based on control images. After an applied watershed, particles under 5 pixels were excluded as they could not be distinguished from background/noise in control images, and those greater than 5 pixels were counted. Analysis of virus infection in cells expressing WT versus TMEM41B SNP variants Statistical analysis was performed in Prism (GraphPad Software

Flavivirus Infection in CRISPR KO Cells for VTT Domain and Autophagy Proteins

Gene disruption was additionally confirmed by next generation sequencing for each clone. (B) HAP1 wildtype (WT) and (n = 3) individual knockout (KO) clones for VTT domain-containing proteins infected with YFV 17D (MOI = 0.005 PFU/cell) for 48 h. (C) HAP1 WT and (n = 3-5) individual KO clones for autophagy genes infected with YFV 17D (MOI = 0.005 PFU/cell) for 48 h. (D and E) Same as panels B-C but infected with DENV-GFP (MOI = 0.1 PFU/cell) for 96 h. (F and G) Same as panels B-C but infected with WNV-GFP (MOI = 10 PFU/cell) for 72 h. (H and I) Same as panels B-C but infected with hPIV-3-GFP (MOI = 0.02 IU/cell) for 48 h

02 IU/cell) for 72 h. Cells were analyzed by flow cytometry and plotted as a percentage of viral antigen positive cells. Dots in panels B-I represent the average of n = 3-5 replicates from individual single cell clones

Flavivirus Infections in Mammalian TMEM41B KO Cells

A549 clones generated with two independent sgRNAs infected with mosquito-borne flaviviruses: YFV 17D

MOI = 0.05 PFU/cell for 72 h

PFU/cell for 48 h; WNV-GFP, MOI = 1 PFU/cell for 72 h

WT and TMEM41B KO A549 clones infected for 48 h with tick-borne flaviviruses at MOIs of 0.02 PFU/cell

clones generated with two independent sgRNAs infected with mosquito-borne flaviviruses: YFV 17D

MOI = 0.05 PFU/cell for 72 h

PFU/cell for 72 h; WNV-GFP, MOI = 0.1 PFU/cell for 48 h

5 clones generated with two independent sgRNAs infected with mosquito-borne flaviviruses: YFV 17D, MOI = 0.0025 PFU/cell for 48 h

MOI = 0.0025 PFU/cell for 48 h

5 clones infected for 48 h with hPIV-3-GFP, MOI = 0.02 IU/cell. Error bars depict SD for n=3 replicates or the indicated number of clones

Plasmids and cell lines generated in this study are available upon request.

The accession number for the sgRNA sequencing data reported in this paper is GEO: GSE162040. Original data for all virus infection experiments in the paper are available upon request.